News

Important Notice for Paragon 28, Inc. (NYSE: FNA) Investors

Important Notice for Paragon 28, Inc. (NYSE: FNA) Investors

Know Your Rights as a Paragon 28, Inc. Investor

As an investor in Paragon 28, Inc. (NYSE: FNA), it is crucial to stay informed about your legal rights. The world of investments can be complex, especially when situations arise that may affect shareholders. This article aims to shed light on the recent developments concerning Paragon 28, providing necessary information for current and potential stakeholders in the company.

What You Need to Know About the Lawsuit

The legal landscape surrounding investments can often leave shareholders feeling vulnerable. Bernstein Liebhard LLP has initiated a class action lawsuit on behalf of investors who purchased or acquired common stock of Paragon 28 during a specific time period. Understanding the implications of this lawsuit is important for individuals who have stakes in the company.

Who is Affected?

If you owned shares of Paragon 28 from May 5, 2023, through September 20, 2024, you may be part of this lawsuit. Questions surrounding investment experiences during this time frame are significant, especially regarding financial losses that may have occurred. Transparency is key during these discussions, and affected shareholders are encouraged to consider their positions carefully.

What Are Your Options?

As a shareholder affected by potential financial discrepancies, it's crucial to weigh your options. If you want to discuss your legal rights or seek more information on the lawsuit, connecting with the investor relations team is a proactive step. Bernstein Liebhard LLP, known for its dedication to investor rights, invites affected shareholders to reach out for guidance.

What Does Being a Lead Plaintiff Mean?

A lead plaintiff plays a significant role within a class-action lawsuit. This position allows an individual to represent the collective interests of all shareholders involved. It’s essential to file the necessary documents before the specified filing date. Notably, being a lead plaintiff isn’t a prerequisite for receiving any financial recovery should the case succeed.

Legal Representation and Fees

It’s worth mentioning that representation by Bernstein Liebhard LLP operates on a contingency fee basis, meaning investors pay no upfront fees or expenses. This structure provides peace of mind to clients and encourages stakeholders to seek redress without the fear of financial burdens.

Background on Bernstein Liebhard LLP

Established with a commitment to investor rights, Bernstein Liebhard LLP has built a strong reputation within the legal community. Since its inception, the firm has successfully recovered substantial sums for its clients, both individual investors and major pension funds. Their experience and accolades, including multiple recognitions, underscore their dedication to achieving favorable outcomes for those they represent.

How to Get Involved

If you have questions or wish to take action as an investor in Paragon 28, it’s recommended to act swiftly. Engage with the law firm to ensure that your voice is heard in this critical matter. By understanding your rights and staying informed, you empower yourself to make decisions that align with your financial interests.

Frequently Asked Questions

What is the class action lawsuit about?

The lawsuit relates to allegations that Paragon 28, Inc. filed false financial statements affecting shareholders during the defined period.

How do I know if I am part of the class action?

If you purchased or acquired shares of Paragon 28, Inc. between May 5, 2023, and September 20, 2024, you may qualify.

What steps must I take if I want to participate?

Make sure to connect with Bernstein Liebhard LLP to discuss your rights and the filing required to participate in the lawsuit.

Will it cost me anything to join the class action?

No, representation with Bernstein Liebhard LLP is on a contingency basis, meaning you pay no upfront fees.

How can I reach out for more information?

You can contact the Investor Relations Manager, Peter Allocco, at (212) 951-2030 or via email. Engaging directly will provide the most pertinent details.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 530

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 72

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 752

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 610

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 506

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 83

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 337

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 248

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 33

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 83

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
ticles